Medicare expands hearing loss treatment access for seniors
H.R. 1921 — Hearing Device Coverage Clarification Act · Filed by Michelle Fischbach (R-MN) · 7 cosponsors · Introduced Mar 6, 2025 · Referred to committee
Your members of Congress
Enter a ZIP to see where your representative and both senators stood on this bill.
Looked up on this device — your ZIP is never stored on our servers.
What it does
This bill directs Medicare to clarify that fully implanted active middle ear hearing devices (surgically placed devices that amplify sound directly to the inner ear) are prosthetics covered by Medicare, not hearing aids excluded from coverage. Currently, Medicare excludes hearing aids from coverage; this bill ensures that a different category of device—one surgically implanted rather than worn—is treated as a prosthetic and therefore covered.
Why we flagged it
The bill is a narrow, technical clarification of Medicare coverage policy for a specific medical device category. It does not create new law but directs an agency to issue guidance distinguishing implanted devices from excluded hearing aids.
What the text implies
- The clarification may trigger coverage determinations for existing beneficiaries who were previously denied implanted middle ear devices; CMS may face retroactive coverage requests.
- Device manufacturers (Cochlear, MED-EL, Oticon Medical) may see increased demand if the clarification removes prior authorization barriers or cost-sharing uncertainty.
- The bill does not specify whether Medicare will cover the surgical implantation procedure itself—only the device classification; coverage of the surgery may remain subject to separate policy.
Section numbers refer to the bill text the analysis read — linked under Primary records below.
Who it affects
Medicare beneficiaries with severe hearing loss who are candidates for implanted middle ear devices gain access to a covered treatment option that was previously excluded. The clarification removes a coverage barrier for a specific population with significant hearing impairment, expanding access to a medical intervention without imposing new costs on other beneficiaries or restricting existing coverage.
Who stands to gain
- manufacturers of implanted middle ear devices (Cochlear Limited, MED-EL, Oticon Medical)
- surgical centers and otolaryngologists performing implantation procedures
- Medicare beneficiaries with severe-to-profound hearing loss
Named in the bill
Centers for Medicare & Medicaid Services (CMS), Medicare program, Social Security Act § 1862(a)(7), 42 CFR § 414.202, implanted active middle ear hearing devices, Cochlear Limited, MED-EL, Oticon Medical
Where it stands
7 cosponsors: 6 Republicans, 1 Democrats.
- Mar 6, 2025 — Introduced · Congress.gov: “Introduced in House”
- Mar 6, 2025 — Referred to House Committee on Ways and Means and House Committee on Energy and Commerce · Congress.gov: “Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a…”
Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.
Money around this bill
1 lobbying clients named this bill on 1 disclosure filings across 1 quarter, Jun 2026 to Jun 2026. Those filings disclosed $0 in lobbying spend. A filing names 2 bills on average, so that figure is what each filing reported, not a share belonging to this bill.
More lobbying clients named this bill than 0% of bills with at least one filing.
Michelle Fischbach, the sponsor, reported $832,550 in PAC receipts in the 2026 cycle.
- Envoy Medical Corporation — $0 on 1 filing
Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.
How this was measured
Analysis — Quorum's AI read the bill text published by Congress.gov (605 characters) on Aug 20, 2026. Section numbers in the findings refer to that text, linked below; transparency and hidden-provision scores are compared against the median of 16,222 analysed bills.
Status and sponsors — Congress.gov's bill record — actions, committee referrals and cosponsors — loaded nightly. The timeline shows status changes, not every procedural action.
Money — Senate Lobbying Disclosure Act filings whose specific-issue field names this bill for quarters ending Jun 2026 to Jun 2026. A filing's amount is reported whole beside the median number of bills a filing names; it is never divided across them. PAC receipts are FEC-reported contributions to the sponsor's candidate committee in the 2026 cycle.
As of — lobbying records through Jul 20, 2026 · page rendered 2026-10-20.
“Medicare expands hearing loss treatment access for seniors” QuorumCivic. https://share.quorumcivic.app/bill/119/hr1921 Report an error
The week in bills
One email, Sunday: what Congress passed, what it changed, and who paid.
One link arrives to confirm the address. It is used for this email and nothing else, and every issue carries an unsubscribe link.